Friday, January 02, 2015 11:13:41 AM
HeartWare Presentation At The J.P. Morgan 33rd Annual Healthcare Conference To Be Webcast
FRAMINGHAM, Jan. 2, 2015: HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the J.P. Morgan 33rd Annual Healthcare Conference at 11:00amET on Tuesday, Jan.13, 2015. The conference is being held Jan. 12-15 at The Westin St. Francis in San Francisco.
http://ir.heartware.com/phoenix.zhtml?c=187755&p=irol-newsArticle&ID=2002665
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM